Related Experiment Video
Updated: Jun 11, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Cardiovascular stress hyperreactivity in babies of smokers and in babies born preterm
Gary Cohen1, Silvano Vella, Heather Jeffery
1Department of Women and Child Health, Neonatal Unit, Karolinska Institute, Elevhemmet H1-02, S-171 76 Stockholm, Sweden. Gary.Cohen@kbh.ki.se
Insights
Infants born preterm or exposed to maternal smoking exhibit heightened cardiovascular reactivity, indicating potential early programming of future heart problems. This silent dysfunction may increase risks for conditions like high blood pressure.
Area of Science:
- Perinatal health
- Cardiovascular physiology
- Developmental programming
Background:
- Preterm birth, low birth weight, and maternal smoking are significant perinatal complications.
- These factors are linked to increased susceptibility to cardiovascular dysfunction later in life.
- Identifying early markers of cardiovascular dysfunction is crucial for public health.
Purpose of the Study:
- To investigate incipient "silent" programming of cardiovascular dysfunction.
- To assess cardiovascular reactivity in infants experiencing adverse perinatal events.
- To identify early indicators of cardiovascular risk.
Main Methods:
- Compared cardiovascular responses in three infant groups: controls, preterm infants, and infants of mothers who smoked.
- Utilized two routine stress tests: 4% carbon dioxide (CO2) breathing and passive head-up tilt (60 degrees).
- Measured blood pressure (BP) and heart rate responses during sleep at 40-42 weeks post-conception.
Main Results:
- Infants of smokers showed a greater BP and heart rate response to CO2 compared to controls.
- Preterm infants had an expected BP but no heart rate response to CO2.
- Both preterm and tobacco-exposed infants exhibited a 3- to 4-fold greater BP rise during head-up tilt compared to controls.
Conclusions:
- Heightened vascular, cardiac, and blood pressure reactivity is observed in preterm infants and infants of smokers.
- Findings support the concept of in utero and early postnatal "programming" of cardiovascular dysfunction.
- This early dysfunction may manifest as later-life complications, including higher blood pressure or sudden infant death syndrome.
Background:
Being born preterm, small, and to a mother who smokes are common perinatal complications with major public health implications. Evidence suggests that each affects the body's structure and function in ways that could increase susceptibility to cardiovascular dysfunction later in life. Here, we used 2 routine stress reactivity tests to identify incipient "silent" programming of cardiovascular dysfunction associated with adverse perinatal events.
Methods And Results:
We studied 29 control babies born at term to nonsmokers, 18 term-born babies of mothers who smoked throughout pregnancy (mean, 15 cigarettes a day), and 31 babies born preterm to nonsmokers. All infants were compared at the same age after conception (ie, at 40 to 42 weeks), during sleep. We analyzed blood pressure (BP) and heart rate responses to breathing 4% CO(2) for 4 minutes or to passive head-up tilt to 60 degrees . BP was measured continuously from a wrist cuff. CO(2) exposure raised heart rate and BP in controls by 10%, and tilt increased their BP by 5%. CO(2) elicited the expected BP but no heart rate response from preterm infants but a much-greater-than-expected BP and heart rate response from babies of smokers. Tilt elicited a 3- to 4-fold greater rise in BP from preterm and tobacco-exposed babies.
Conclusions:
Vascular, cardiac, and blood pressure reactivity is heightened in babies born preterm or to smokers. The findings are consistent with in utero and early postnatal "programming" of human cardiovascular dysfunction by adverse circumstances. This incipient dysfunction may be an early manifestation of processes that lead to other problems or complications later on (eg, higher BP or sudden infant death syndrome).
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Pulmonary Cycle: Exhalation
Asthma-I: Introduction
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Psychosexual Stages of Personality: Oral
Weaning, typically occurring around the age...
Stress Prevention and Stress Management Techniques IV

